Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amyris, Inc.    AMRS

AMYRIS, INC.

(AMRS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
2.27(c) 2.3(c) 2.42(c) 2.62(c) 2.8501 Last
2 800 744 2 019 481 3 247 084 2 770 995 4 594 345 Volume
+0.89% +1.32% +5.22% +8.26% +8.78% Change
More quotes
Financials (USD)
Sales 2020 166 M - -
Net income 2020 -313 M - -
Net Debt 2020 20,0 M - -
P/E ratio 2020 -1,65x
Yield 2020 -
Sales 2021 255 M - -
Net income 2021 -92,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,78x
Yield 2021 -
Capitalization 627 M 627 M -
EV / Sales 2020 3,89x
Capi. / Sales 2021 2,46x
Nbr of Employees 561
Free-Float 66,8%
More Financials
Company
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced... 
More about the company
Notations Surperformance© of Amyris, Inc.
Trading Rating : - Investor Rating :
More Ratings
All news about AMYRIS, INC.
11/24AMYRIS : to Present at Evercore ISI's 3rd Annual HealthCONx Conference on Decemb..
AQ
11/23AMYRIS : To Present at Evercore ISI's 3rd Annual HealthCONx Conference on Decemb..
PR
11/23AMYRIS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
AQ
11/20AMYRIS : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
11/09AMYRIS : Keeping Life Sweet, Sustainable, & Calorie-Free
PU
11/06AMYRIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
11/06AMYRIS : Reports Third Quarter 2020 Financial Results
AQ
11/05AMYRIS, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
11/05AMYRIS, INC. : Reports Third Quarter 2020 Financial Results
PR
11/02AMYRIS : and Rosie Huntington-Whiteley Announce Creation of New Clean Beauty Bra..
AQ
10/30AMYRIS : And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Bra..
PR
10/26AMYRIS : to Host Third Quarter 2020 Financial Results Conference Call on Novembe..
AQ
10/26INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Amyri..
BU
10/24GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Inv..
BU
10/23AMYRIS : To Host Third Quarter 2020 Financial Results Conference Call On Novembe..
PR
More news
News in other languages on AMYRIS, INC.

- No features available -

More news
Chart AMYRIS, INC.
Duration : Period :
Amyris, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMYRIS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 6,78 $
Last Close Price 2,62 $
Spread / Highest target 320%
Spread / Average Target 159%
Spread / Lowest Target 27,9%
EPS Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey Mark Duyk Chairman
Eduardo Alvarez Chief Operating Officer
Hermanus Kieftenbeld Chief Financial Officer
Sunil Chandran Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS, INC.-15.21%627
SAUDI BASIC INDUSTRIES CORPORATION4.26%77 272
AIR LIQUIDE7.77%76 248
WANHUA CHEMICAL GROUP CO., LTD.49.87%41 561
LYONDELLBASELL INDUSTRIES N.V.-3.84%30 337
HENGLI PETROCHEMICAL CO.,LTD.59.20%28 332